Kaleem Ahmad in Hackensack, New Jersey

Home New Jersey Hackensack

Kaleem Ahmad has Hematology/oncology as his primary medical specialty. Their primary office is: 30 Prospect Ave in Hackensack, New Jersey. There are 2 additional office locations for Kaleem Ahmad that can be viewed towards the end of their profile.

They're a part of the: Regional Cancer Care Associates Llc medical group which has around 111 members. You can call their office at 201-996-2210 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Rutgers R W Johnson Medical School (cam/new Bruns/pisc) and graduated in 1982 (around 42 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Kaleem Ahmad Office Phone and Directions

Kaleem Ahmad
Regional Cancer Care Associates Llc
30 Prospect Ave
Hackensack, New Jersey 07601
201-996-2210

Patient Ratings
Please rate your experience with Kaleem Ahmad below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 201-996-2210

Enter a starting address:

Healthcare Info for Kaleem Ahmad

Medical School: Rutgers R W Johnson Medical School (cam/new Bruns/pisc)
Graduation Year: 1982
The Primary Medical Specialty for Kaleem Ahmad is listed as: Hematology/oncology
Approximate Years of Experience: 42
PAC (PECOS ID)#: 8921155854
NPI #: 1629065982
NPI Created On: 10/03/2005
NPI Last Updated Listed as: 05/12/2017
Primary Taxonomy Code: 207RH0003X
License Number:
MA062569
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

AmeriHealth New Jersey
Blue Cross Blue Shield
Humana
Oscar Garden State Insurance Corporation
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, Indian.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Complete blood cell count (red cells, white blood cell, platelets), automated test
Blood test, clotting time
Anti-clotting management for patient taking warfarin
Hydration infusion into a vein
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy, prevention, or diagnosis
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Application of on-body injector for injection under skin
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
Irrigation of implanted venous access drug delivery device
Therapeutic removal of whole blood to correct blood level imbalance
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 5 minutes
Established patient office or other outpatient visit, typically 15 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788496167

Being Disputed:: No

Product Related: No

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788496169

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788496171

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781007549

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781007551

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781007553

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781007559

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781007555

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781007557

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793820359

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Additional Office Locations

1. Regional Cancer Care Associates Llc
210 Route Us 9 S 106
Marmora, NJ 08223
Group Members: 111

Enter a starting address:

2. Regional Cancer Care Associates Llc
210 S Shore Rd
Marmora, NJ 08223
Suite 106
Group Members: 111

Phone: 201-996-2210

Enter a starting address:

Hematology/oncology Professionals in Hackensack

1.
Mark Pascal

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

2.
Richard Scher DO

30 Prospect Ave
Hackensack, NJ
Regional Cancer Care Associates Llc

3.
Harry Harper

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

4.
Sukhdeep Kaur

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

5.
Robert Tassan MD

30 Prospect Ave
Hackensack, NJ
Regional Cancer Care Associates Llc

6.
Kelley Mowatt Pesce

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

Providers in Regional Cancer Care Associates Llc

1.May Abdo-matkiwsky Do

30 Prospect Ave
Hackensack Nj 07601-1915
Regional Cancer Care Associates Llc
Hematology/oncology

2.May Abdo-matkiwsky Do

89 Sparta Ave
Sparta Nj 07871-1791
Regional Cancer Care Associates Llc
Hematology/oncology

3.Manmeet Ahluwalia

57 Kent Rd
Howell Nj 07731-2452
Regional Cancer Care Associates Llc
Hematology/oncology

4.Manmeet Ahluwalia

40 Bey Lea Rd
Toms River Nj 08753-2900
Regional Cancer Care Associates Llc
Hematology/oncology

5.Kaleem Ahmad

30 Prospect Ave
Hackensack Nj 07601-1915
Regional Cancer Care Associates Llc
Hematology/oncology

6.Kaleem Ahmad

210 Route Us 9 S 106
Marmora Nj 08223-1271
Regional Cancer Care Associates Llc
Hematology/oncology

View all 111 members of Regional Cancer Care Associates Llc medical group